Beasley, Allen, Crow, Methvin, Portis & Miles, P.C.

The medication metoclopramide, used in the treatment of some gastrointestional conditions, has received much press lately. Earlier this year the drug fell under a black box warning by the Food and Drug Administration (FDA) after studies showed that patients who took the prescription medication were at high risk of experiencing involuntary movements of their face, hands and torso. The condition, known as Tardive Dyskinesia, is a debilitating disorder that often doesn’t go away even after the offending medication has been discontinued. The result has been measured in countless lawsuits against manufacturers of metoclopramide.

Read the rest of this entry »

Questcor Pharmaceuticals Inc. has just released the study results of its Phase II clinical trial on a metoclopramide nasal spray for the treatment of diabetic gastroparesis, a condition in which contents remain in the stomach for a longer period of time than normal. Left untreated, gastroparesis can lead to fluctuations in blood glucose, general malnutrition, intestinal obstruction and bacterial infection.

Read the rest of this entry »